AEON Biopharma, Inc.AEON

$0.67-0.01 (-0.83%)

AMEXHealthcare24:00 UTC

Company snapshot

Market Cap

$8M

Micro-cap

-99%

2023 — today

10-Year Price

-100%

2023 — today

52-Week Range

$0.66$1.40

Current $0.67· 1%

AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.

Valuation in context

P/E ratio

-0.1

N/A

Not meaningful — company is unprofitable

P/B ratio

-0.5

N/A

Not meaningful — company is unprofitable

FCF Yield

-148.8%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when AEON is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.